Am J Psychiatry 157:351-359, March 2000
© 2000 American Psychiatric Association
Nortriptyline Versus Fluoxetine in the Treatment of Depression and in Short-Term Recovery After Stroke: A Placebo-Controlled, Double-Blind Study
Robert G. Robinson, M.D.,
Susan K. Schultz, M.D.,
Carlos Castillo, M.D.,
Teresa Kopel, M.A.,
J. Todd Kosier, B.S.,
R. Mark Newman, M.D.,
Kathryn Curdue, M.D.,
Gustavo Petracca, M.D., and
Sergio E. Starkstein, M.D., Ph.D.
OBJECTIVE: This study compared nortriptyline and fluoxetine with placebo in the treatment of depression and in recovery from physical and cognitive impairments after stroke. METHOD: A total of 104 patients with acute stroke enrolled between 1991 and 1997 entered a double-blind randomized study comparing nortriptyline, fluoxetine, and placebo over 12 weeks of treatment. The majority of patients were recruited from a rehabilitation hospital in Des Moines, Iowa, but other enrollment sites were also used. Both depressed and nondepressed patients were enrolled to determine whether improved recovery could be mediated by mechanisms unrelated to depression. Nortriptyline in doses of 25 mg/day gradually increased to 100 mg/day or fluoxetine in doses of 10 mg/day gradually increased to 40 mg/day or identical placebo were given over 12 weeks. Response to treatment of depression for individual patients was defined as a greater-than-50% reduction in scores on the Hamilton Rating Scale for Depression and no longer fulfilling diagnostic criteria for major or minor depression. Improved recovery for a treatment group was defined as a significantly higher mean score from baseline to end of the treatment trial, compared with patients treated with placebo, on measures of impairment in activities of daily living and levels of cognitive and social functioning. RESULTS: Nortriptyline produced a significantly higher response rate than fluoxetine or placebo in treating poststroke depression, in improving anxiety symptoms, and in improving recovery of activities of daily living as measured by the Functional Independence Measure. There was no effect of nortriptyline or fluoxetine on recovery of cognitive or social functioning among depressed or nondepressed patients. Fluoxetine in increasing doses of 10–40 mg/day led to an average weight loss of 15.1 pounds (8% of initial body weight) over 12 weeks of treatment that was not seen with nortriptyline or placebo. CONCLUSIONS: Given the doses of medication used in this study, nortriptyline was superior to fluoxetine in the treatment of poststroke depression. Demonstrating a benefit of antidepressant treatment in recovery from stroke may require the identification of specific subgroups of patients, alternative measurement scales, or the optimal time of treatment.
This article has been cited by other articles:
|
|
|
|
 
R. G. Robinson, R. E. Jorge, and K. Clarence-Smith
Double-Blind Randomized Treatment of Poststroke Depression Using Nefiracetam
J Neuropsychiatry Clin Neurosci,
May 1, 2008;
20(2):
178 - 184.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Narushima, D. J. Moser, and R. G. Robinson
Correlation Between Denial of Illness and Executive Function Following Stroke: A Pilot Study
J Neuropsychiatry Clin Neurosci,
February 1, 2008;
20(1):
96 - 100.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. G. Fiedorowicz, K. Takezawa, and R. G. Robinson
Risk Factors for and Correlates of Poststroke Depression Following Discontinuation of Antidepressants
J Neuropsychiatry Clin Neurosci,
November 1, 2007;
19(4):
399 - 405.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Townend, M. Brady, and K. McLaughlan
A Systematic Evaluation of the Adaptation of Depression Diagnostic Methods for Stroke Survivors Who Have Aphasia
Stroke,
November 1, 2007;
38(11):
3076 - 3083.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Narushima, S. Paradiso, D. J. Moser, R. Jorge, and R. G. Robinson
Effect of antidepressant therapy on executive function after stroke
The British Journal of Psychiatry,
March 1, 2007;
190(3):
260 - 265.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Chen, J. J Guo, S. Zhan, and N. C Patel
Treatment Effects of Antidepressants in Patients with Post-Stroke Depression: A Meta-Analysis
Ann. Pharmacother.,
December 1, 2006;
40(12):
2115 - 2122.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Chen and J. J. Guo
Meta-Analysis of Antidepressant Treatment for Patients With Poststroke Depression
Stroke,
June 1, 2006;
37(6):
1365 - 1366.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Choi-Kwon, S. W. Han, S. U. Kwon, D.-W. Kang, J. M. Choi, and J. S. Kim
Fluoxetine Treatment in Poststroke Depression, Emotional Incontinence, and Anger Proneness: A Double-Blind, Placebo-Controlled Study
Stroke,
January 1, 2006;
37(1):
156 - 161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. E. Lotrich and B. G. Pollock
Aging and Clinical Pharmacology: Implications for Antidepressants
J. Clin. Pharmacol.,
October 1, 2005;
45(10):
1106 - 1122.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Bates, J. Y. Choi, P. W. Duncan, J. J. Glasberg, G. D. Graham, R. C. Katz, K. Lamberty, D. Reker, and R. Zorowitz
Veterans Affairs/Department of Defense Clinical Practice Guideline for the Management of Adult Stroke Rehabilitation Care: Executive Summary
Stroke,
September 1, 2005;
36(9):
2049 - 2056.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. W. Duncan, R. Zorowitz, B. Bates, J. Y. Choi, J. J. Glasberg, G. D. Graham, R. C. Katz, K. Lamberty, and D. Reker
Management of Adult Stroke Rehabilitation Care: A Clinical Practice Guideline
Stroke,
September 1, 2005;
36(9):
e100 - e143.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Hackett, C. S. Anderson, and A. O. House
Management of Depression After Stroke: A Systematic Review of Pharmacological Therapies
Stroke,
May 1, 2005;
36(5):
1092 - 1097.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. C. Kales, D. F. Maixner, and A. M. Mellow
Cerebrovascular Disease and Late-Life Depression
Am J Geriatr Psychiatry,
February 1, 2005;
13(2):
88 - 98.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. J. Fochtmann and A. J. Gelenberg
Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd Edition
Focus,
January 1, 2005;
3(1):
34 - 42.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. I. Papakostas, T. Petersen, J. Pava, E. Masson, J. J. Worthington III, J. E. Alpert, M. Fava, and A. A. Nierenberg
Hopelessness and Suicidal Ideation in Outpatients With Treatment-Resistant Depression: Prevalence and Impact on Treatment Outcome
Focus,
January 1, 2005;
3(1):
140 - 145.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J C Davies, P. R Jackson, J. Potokar, and D. J Nutt
Treatment of anxiety and depressive disorders in patients with cardiovascular disease
BMJ,
April 17, 2004;
328(7445):
939 - 943.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. G. Sugden and J. A. Bourgeois
Modafinil Monotherapy in Poststroke Depression
Psychosomatics,
February 1, 2004;
45(1):
80 - 81.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. E. Jorge, R. G. Robinson, S. Arndt, and S. Starkstein
Mortality and Poststroke Depression: A Placebo-Controlled Trial of Antidepressants
Am J Psychiatry,
October 1, 2003;
160(10):
1823 - 1829.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Charney, C. F. Reynolds III, L. Lewis, B. D. Lebowitz, T. Sunderland, G. S. Alexopoulos, D. G. Blazer, I. R. Katz, B. S. Meyers, P. A. Arean, et al.
Depression and Bipolar Support Alliance Consensus Statement on the Unmet Needs in Diagnosis and Treatment of Mood Disorders in Late Life
Arch Gen Psychiatry,
July 1, 2003;
60(7):
664 - 672.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rasmussen, M. Lunde, D. L. Poulsen, K. Sorensen, S. Qvitzau, and P. Bech
A Double-Blind, Placebo-Controlled Study of Sertraline in the Prevention of Depression in Stroke Patients
Psychosomatics,
June 1, 2003;
44(3):
216 - 221.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kimura, A. Tateno, and R. G. Robinson
Treatment of Poststroke Generalized Anxiety Disorder Comorbid With Poststroke Depression: Merged Analysis of Nortriptyline Trials
Am J Geriatr Psychiatry,
June 1, 2003;
11(3):
320 - 327.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Narushima, K.-L. Chan, J. T. Kosier, and R. G. Robinson
Does Cognitive Recovery After Treatment of Poststroke Depression Last? A 2-Year Follow-Up of Cognitive Function Associated With Poststroke Depression
Am J Psychiatry,
June 1, 2003;
160(6):
1157 - 1162.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Huffman and T. A. Stern
Acute Psychiatric Manifestations of Stroke: A Clinical Case Conference
Psychosomatics,
February 1, 2003;
44(1):
65 - 75.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Tateno, M. Kimura, and R. G. Robinson
Phenomenological Characteristics of Poststroke Depression: Early- Versus Late-Onset
Am J Geriatr Psychiatry,
October 1, 2002;
10(5):
575 - 582.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Tateno, Y. Murata, and R. G. Robinson
Comparison of Cognitive Impairment Associated With Major Depression Following Stroke Versus Traumatic Brain Injury
Psychosomatics,
August 1, 2002;
43(4):
295 - 301.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Beblo and M. Driessen
No Melancholia in Poststroke Depression? A Phenomenologic Comparison of Primary and Poststroke Depression
J Geriatr Psychiatry Neurol,
April 1, 2002;
15(1):
44 - 49.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. Turner-Stokes and N. Hassan
Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 1: Diagnosis, frequency and impact
Clinical Rehabilitation,
March 1, 2002;
16(3):
231 - 247.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. Turner-Stokes and N. Hassan
Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 2: Treatment alternatives
Clinical Rehabilitation,
March 1, 2002;
16(3):
248 - 260.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. Turner-Stokes, N. Hassan, K. Pierce, and F. Clegg
Managing depression in brain injury rehabilitation: the use of an integrated care pathway and preliminary report of response to sertraline
Clinical Rehabilitation,
March 1, 2002;
16(3):
261 - 268.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. H. Mulsant, B. G. Pollock, R. Nebes, M. D. Miller, R. A. Sweet, J. Stack, P. R. Houck, S. Bensasi, S. Mazumdar, and C. F. Reynolds III
A Twelve-Week, Double-Blind, Randomized Comparison of Nortriptyline and Paroxetine in Older Depressed Inpatients and Outpatients
Am J Geriatr Psychiatry,
November 1, 2001;
9(4):
406 - 414.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. Lenze, J. C. Rogers, L. M. Martire, B. H. Mulsant, B. L. Rollman, M. A. Dew, R. Schulz, and C. F. Reynolds III
The Association of Late-Life Depression and Anxiety With Physical Disability: A Review of the Literature and Prospectus for Future Research
Am J Geriatr Psychiatry,
May 1, 2001;
9(2):
113 - 135.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
K. FRANCO and S. MALHOTRA
Poststroke Depression
Am J Psychiatry,
April 1, 2001;
158(4):
658-a - 659.
[Full Text]
|
|
|
|
|
|
|
A. House, C. Anderson, M. Hackett, R. G. Robinson, M. Kimura, and T. Kosier
Authors Should Be Accurate When Describing Study Design Response
Stroke,
April 1, 2001;
32(4):
1048 - 1049.
[Full Text]
|
|
|
|
|
|
|
D. Weintraub
Nortriptyline in Geriatric Depression Resistant to Serotonin Reuptake Inhibitors: Case Series
J Geriatr Psychiatry Neurol,
March 1, 2001;
14(1):
28 - 32.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E. Chemerinski, R. G. Robinson, and J. T. Kosier
Improved Recovery in Activities of Daily Living Associated With Remission of Poststroke Depression
Stroke,
January 1, 2001;
32(1):
113 - 117.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
Y. Murata, M. Kimura, and R. G. Robinson
Does Cognitive Impairment Cause Poststroke Depression?
Am J Geriatr Psychiatry,
November 1, 2000;
8(4):
310 - 317.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. Kimura, R. G. Robinson, and J. T. Kosier
Treatment of Cognitive Impairment After Poststroke Depression : A Double-Blind Treatment Trial
Stroke,
July 1, 2000;
31(7):
1482 - 1486.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
How Do SSRIs and TCAs Stack Up Against Each Other?
Journal Watch Psychiatry,
May 1, 2000;
2000(501):
3 - 3.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2000
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
